FAB-144
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| PubChem (CID) | 102135350 |
| ChemSpider | 32055552 |
| Chemical and physical data | |
| Formula | C20H27FN2O |
| Molar mass | 330.4 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is the indazole analogue of XLR-11.
Legal status
Sweden's public health agency suggested classifying FAB-144 as hazardous substance on November 10, 2014.[2]
See also
References
- ↑ "FAB-144". Cayman Chemical. Retrieved 23 July 2015.
- ↑ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.
This article is issued from Wikipedia - version of the 6/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.